Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022		34,060
Balance, value at Dec. 31, 2022	$ 822,099	$ 340	$ 322,873	$ 627,978	$ (3,432)	$ (125,660)
Beginning balance (in shares) at Dec. 31, 2022						3,199
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	21,099			21,099
Foreign currency translation adjustment	(107)				(107)
Stock compensation expense	1,594		1,594
Net settlement of restricted stock units (in shares)		88				36
Net settlement of restricted stock units	(1,929)	$ 1	(1)			$ (1,929)
Common stock repurchased under stock repurchase program (in shares)						154
Common stock repurchased under stock repurchase program	(7,369)					$ (7,369)
Ending balance (in shares) at Mar. 31, 2023		34,148
Balance, value at Mar. 31, 2023	$ 835,387	$ 341	324,466	649,077	(3,539)	$ (134,958)
Ending balance (in shares) at Mar. 31, 2023						3,389
Beginning balance (in shares) at Dec. 31, 2023	34,219	34,219
Balance, value at Dec. 31, 2023	$ 914,998	$ 342	332,621	738,511	(2,114)	$ (154,362)
Beginning balance (in shares) at Dec. 31, 2023	3,778					3,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 24,946			24,946
Foreign currency translation adjustment	(964)				(964)
Stock compensation expense	2,639		2,639
Net settlement of restricted stock units (in shares)		47				19
Net settlement of restricted stock units	$ (1,434)	$ 1	(1)			$ (1,434)
Ending balance (in shares) at Mar. 31, 2024	34,219	34,266
Balance, value at Mar. 31, 2024	$ 940,185	$ 343	$ 335,259	$ 763,457	$ (3,078)	$ (155,796)
Ending balance (in shares) at Mar. 31, 2024	3,797					3,797